Associate Professor Luke Selth leads the Prostate Cancer Research Group at Flinders Health and Medical Research Institute, Flinders University. His research is focussed on gaining a better understanding of the mechanisms underlying prostate cancer metastasis and therapy resistance, with specific emphasis on transcriptional and epigenetic regulators of these processes. His team uses this information to identify and develop novel therapeutic strategies and biomarkers. Selth’s research programs are currently funded by Cancer Council SA, Movember, National Health and Medical Research Council, the National Breast Cancer Foundation and The Hospital Research Foundation.
Abstracts this author is presenting: